Edwards Lifesciences Corp
EW
Company Profile
Business description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
Contact
One Edwards Way
IrvineCA92614
USAT: +1 949 250-2500
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
19,800
Edwards Lifesciences Corp News & Analysis
personal-finance
US stock market outlook: tariffs are 2025's wild card
Macrodynamic tailwinds persist, but stocks are already priced to perfection. Will tariffs derail the market in 2025?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,568.50 | 30.90 | -0.36% |
| CAC 40 | 7,452.42 | 36.93 | -0.49% |
| DAX 40 | 20,329.94 | 10.63 | -0.05% |
| Dow JONES (US) | 42,635.20 | 106.84 | 0.25% |
| FTSE 100 | 8,251.03 | 5.75 | 0.07% |
| HKSE | 19,360.31 | 80.47 | 0.42% |
| NASDAQ | 19,478.88 | 10.80 | -0.06% |
| Nikkei 225 | 39,678.93 | 302.13 | -0.76% |
| NZX 50 Index | 12,974.86 | 68.25 | -0.52% |
| S&P 500 | 5,918.25 | 9.22 | 0.16% |
| S&P/ASX 200 | 8,318.90 | 30.20 | -0.36% |
| SSE Composite Index | 3,226.02 | 4.14 | -0.13% |